Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $2.91 billion. The enterprise value is $2.03 billion.
Important Dates
The last earnings date was Monday, August 11, 2025, before market open.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KYMR has 71.50 million shares outstanding. The number of shares has increased by 21.55% in one year.
Current Share Class | 71.50M |
Shares Outstanding | 71.50M |
Shares Change (YoY) | +21.55% |
Shares Change (QoQ) | +0.38% |
Owned by Insiders (%) | 1.30% |
Owned by Institutions (%) | 72.60% |
Float | 47.08M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 72.18 |
Forward PS | 45.81 |
PB Ratio | 2.96 |
P/TBV Ratio | 3.00 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 45.51 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.32, with a Debt / Equity ratio of 0.09.
Current Ratio | 8.32 |
Quick Ratio | 8.06 |
Debt / Equity | 0.09 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -996.36 |
Financial Efficiency
Return on equity (ROE) is -33.26% and return on invested capital (ROIC) is -21.30%.
Return on Equity (ROE) | -33.26% |
Return on Assets (ROA) | -19.92% |
Return on Invested Capital (ROIC) | -21.30% |
Return on Capital Employed (ROCE) | -29.89% |
Revenue Per Employee | $237,824 |
Profits Per Employee | -$1.47M |
Employee Count | 188 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.14% in the last 52 weeks. The beta is 2.18, so KYMR's price volatility has been higher than the market average.
Beta (5Y) | 2.18 |
52-Week Price Change | -4.14% |
50-Day Moving Average | 44.79 |
200-Day Moving Average | 39.00 |
Relative Strength Index (RSI) | 41.83 |
Average Volume (20 Days) | 605,521 |
Short Selling Information
The latest short interest is 7.75 million, so 10.85% of the outstanding shares have been sold short.
Short Interest | 7.75M |
Short Previous Month | 7.57M |
Short % of Shares Out | 10.85% |
Short % of Float | 16.47% |
Short Ratio (days to cover) | 12.29 |
Income Statement
In the last 12 months, KYMR had revenue of $44.71 million and -$275.43 million in losses. Loss per share was -$3.48.
Revenue | 44.71M |
Gross Profit | -246.16M |
Operating Income | -311.86M |
Pretax Income | -157.85M |
Net Income | -275.43M |
EBITDA | -305.06M |
EBIT | -311.86M |
Loss Per Share | -$3.48 |
Full Income Statement Balance Sheet
The company has $665.45 million in cash and $85.71 million in debt, giving a net cash position of $877.36 million or $12.27 per share.
Cash & Cash Equivalents | 665.45M |
Total Debt | 85.71M |
Net Cash | 877.36M |
Net Cash Per Share | $12.27 |
Equity (Book Value) | 971.48M |
Book Value Per Share | 13.77 |
Working Capital | 640.79M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$251.01 million and capital expenditures -$1.91 million, giving a free cash flow of -$252.92 million.
Operating Cash Flow | -251.01M |
Capital Expenditures | -1.91M |
Free Cash Flow | -252.92M |
FCF Per Share | -$3.54 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -697.51% |
Pretax Margin | -616.03% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.55% |
Shareholder Yield | -21.55% |
Earnings Yield | -9.46% |
FCF Yield | -8.69% |
Dividend Details Analyst Forecast
The average price target for KYMR is $58.94, which is 44.67% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $58.94 |
Price Target Difference | 44.67% |
Analyst Consensus | Strong Buy |
Analyst Count | 16 |
Revenue Growth Forecast (5Y) | 53.90% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 8.39 and a Piotroski F-Score of 1.
Altman Z-Score | 8.39 |
Piotroski F-Score | 1 |